|
1
|
Cakir A, Akgun Z, Fayda M and Agaoglu F:
Comparison of three dimensional conformal radiation therapy,
intensity modulated radiation therapy and volumetric modulated arc
therapy for low radiation exposure of normal tissue in patients
with prostate cancer. Asian Pac J Cancer Prev. 16:3365–3370. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
IARC, . GLOBOCAN 2012: Estimated Cancer
Incidence, Mortality and Prevalence Worldwide in 2012. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspxJune
16–2018
|
|
3
|
Choi Y, Kim SY, Kim SH, Yang J, Park K and
Byun Y: Inhibition of tumor growth by biodegradable microspheres
containing all-trans-retinoic acid in a human head-and-neck cancer
xenograft. Int J Cancer. 107:145–148. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Curtis RE, Freedman DM, Ron E, Ries LAG,
Hacker DG, Edwards BK, Tucker MA and Fraumeni JF Jr: New
malignancies among cancer survivors: SEER Cancer Registries,
1973–2000. National Cancer Institute; https://seer.cancer.gov/archive/publications/mpmono/MPMonograph_complete.pdfSeptember
18–2017
|
|
5
|
Morris LG, Sikora AG, Hayes RB, Patel SG
and Ganly I: Anatomic sites at elevated risk of second primary
cancer after an index head and neck cancer. Cancer Causes Control.
22:671–679. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rose BS, Jeong JH, Nath SK, Lu SM and Mell
LK: Population-based study of competing mortality in head and neck
cancer. J Clin Oncol. 29:3503–3509. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chuang SC, Scelo G, Tonita JM, Tamaro S,
Jonasson JG, Kliewer EV, Hemminki K, Weiderpass E, Pukkala E,
Tracey E, et al: Risk of second primary cancer among patients with
head and neck cancers: A pooled analysis of 13 cancer registries.
Int J Cancer. 123:2390–2396. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Plaxton NA, Brandon DC, Corey AS, Harrison
CE, Karagulle Kendi AT, Halkar RK and Barron BJ: Characteristics
and limitations of FDG PET/CT for imaging of squamous cell
carcinoma of the head and neck: A comprehensive review of anatomy,
metastatic pathways, and image findings. AJR Am J Roentgenol.
205:W519–W531. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Al-Ibraheem A, Buck A, Krause BJ,
Scheidhauer K and Schwaiger M: Clinical applications of FDG PET and
PET/CT in head and neck cancer. J Oncol. 2009:2087252009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lonneux M, Hamoir M, Reychler H, Maingon
P, Duvillard C, Calais G, Bridji B, Digue L, Toubeau M and Grégoire
V: Positron emission tomography with [18F]fluorodeoxyglucose
improves staging and patient management in patients with head and
neck squamous cell carcinoma: A multicenter prospective study. J
Clin Oncol. 28:1190–1195. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Manca G, Vanzi E, Rubello D, Giammarile F,
Grassetto G, Wong KK, Perkins AC, Colletti PM and Volterrani D:
(18)F-FDG PET/CT quantification in head and neck squamous cell
cancer: Principles, technical issues and clinical applications. Eur
J Nucl Med Mol Imaging. 43:1360–1375. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Takata T and Slootweg PJ: Tumours of the
oral cavity and mobile tongueWorld Health Organization (WHO)
classification of head and neck tumours. El-Naggar AK, Chan JKC,
Grandis JR, Takata T and Slootweg PJ: 4th. IARC Press; Lyon: pp.
108–111. 2017
|
|
13
|
Sobin LH, Gospodarowicz MK and Wittekind
C: International Union Against CancerTNM classification of
malignant tumors. 7th. Wiley-Blackwell; New York, NY: 2009
|
|
14
|
Licitra L, Grandi C, Guzzo M, Mariani L,
Lo Vullo S, Valvo F, Quattrone P, Valagussa P, Bonadonna G,
Molinari R and Cantù G: Primary chemotherapy in resectable oral
cavity squamous cell cancer: A randomized controlled trial. J Clin
Oncol. 21:327–333. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yamamoto E, Kohama G, Sunakawa H, Iwai M
and Hiratsuka H: Mode of invasion, bleomycin sensitivity, and
clinical course in squamous cell carcinoma of the oral cavity.
Cancer. 51:2175–2180. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mantsopoulos K, Goncalves M and Iro H:
Transdermal scopolamine for the prevention of a salivary fistula
after parotidectomy. Br J Oral Maxillofac Surg. 56:212–215. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shimm DS, Berk FK, Tilsner TJ and
Coulthard SW: Low-dose radiation therapy for benign salivary
disorders. Am J Clin Oncol. 15:76–78. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Maurer P, Eckert AW, Kriwalsky MS and
Schubert J: Scope and limitations of methods of mandibular
reconstruction: A long-term follow-up. Br J Oral Maxillofac Surg.
48:100–104. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Moura LB, Carvalho PH, Xavier CB, Post LK,
Torriani MA, Santagata M and Chagas Júnior OL: Autogenous
non-vascularized bone graft in segmental mandibular reconstruction:
A systematic review. Int J Oral Maxillofac Surg. 45:1388–1394.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
National Comprehensive Cancer Network, .
Head and Neck Cancers Version 1. 2018.https://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdfApril
18–2018
|
|
21
|
Weedon D, Morgan MB, Gross C, Nagore E and
Yu LL: Squamous cell carcinomaPathology and Genetics of Skin
Tumours. LeBoit PE, Burg G and Weedon DAS: IARC Press; Lyon: pp.
20–25. 2006
|
|
22
|
Jain KS, Sikora AG, Baxi SS and Morris LG:
Synchronous cancers in patients with head and neck cancer: Risks in
the era of human papillomavirus-associated oropharyngeal cancer.
Cancer. 119:1832–1837. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gleason DF and Mellinger GT: Prediction of
prognosis for prostatic adenocarcinoma by combined histological
grading and clinical staging. J Urol. 111:58–64. 1974. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Warren S and Gates O: Multiple primary
malignant tumors: A survey of the literature and a statistical
study. Am J Cancer. 16:1358–1414. 1932.
|
|
25
|
Moertel CG, Dockerty MB and Baggenstoss
AH: Multiple primary malignant neoplasms. I. Introduction and
presentation of data. Cancer. 14:221–230. 1961. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gordon BS: Triple synchronous primary
carcinoma. Arch Pathol (Chic). 45:56–64. 1948.PubMed/NCBI
|
|
27
|
Goodner JT and Watson WL: Cancer of the
esophagus; its association with other primary cancers. Cancer.
9:1248–1252. 1956. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bittorf B, Kessler H, Merkel S, Brückl W,
Wein A, Ballhausen WG, Hohenberger W and Günther K: Multiple
primary malignancies: An epidemiological and pedigree analysis of
57 patients with at least three tumours. Eur J Surg Oncol.
27:302–313. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rho NK, Choi SJ and Lee ES: A case of
multiple Bowen's disease with squamous cell carcinoma of the larynx
and adenocarcionoma of the prostate. J Dermatol. 29:516–521. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rai RS, Deb P, Rai R, Gupta E and Panayach
JS: Synchronous primary triple neoplasia (renal cell carcinoma and
prostate cancer in combination with thyroid neoplasm). Report of an
unusual case. Minerva Urol Nefrol. 59:451–454. 2007.PubMed/NCBI
|
|
31
|
Jaudah AM, Kanaan HD and Hasan JF:
Multiple primary malignancies of thyroid, kidneys and prostate:
Synchronous and metachronous presentation in one patient. New Egypt
J Med. 39:33–36. 2008.
|
|
32
|
Yamashita M, Jinbu Y, Hiratsuka M,
Shinozaki Y, Itoh H and Kusama M: A case of quadruple primary
cancer including lower lip cancer. Asian J Oral Maxillofac Surg.
22:172–174. 2010. View Article : Google Scholar
|
|
33
|
Salem A, Abu-Hijlih R, Abdelrahman F,
Turfa R, Amarin R, Farah N, Sughayer M, Almousa A and Khader J:
Multiple primary malignancies: Analysis of 23 patients with at
least three tumors. J Gastrointest Cancer. 43:437–443. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Guven BC, Guzide Ayse GO and Ramazan S:
Triple synchronous primary cancers of thyroid, bladder and
prostate: A case report. Kuwait Med J. 46:62–64. 2014.
|
|
35
|
Mukaiyama Y, Suzuki M, Morikawa T, Mori Y,
Takeshima Y, Fujimura T, Fukuhara H, Nakagawa T, Nishimatsu H, Kume
H and Homma Y: Multiple primary malignant neoplasms of the glottis,
renal pelvis, urinary bladder, oral floor, prostate, and esophagus
in a Japanese male patient: A case report. World J Surg Oncol.
12:2942014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mohammed A, Al-Zahrani A, Mansour M,
Ghanem H, El Saify A and Hani EK: Triple primary carcinomas:
Prostatic adenocarcinoma, bladder urethral carcinoma and papillary
thyroid carcinoma: A case report. Am J Cancer Case Rep. 3:24–28.
2015.
|
|
37
|
Testori A, Cioffi U, De Simone M, Bini F,
Vaghi A, Lemos AA, Ciulla MM and Alloisio M: Multiple primary
synchronous malignant tumors. BMC Res Notes. 27:7302015. View Article : Google Scholar
|
|
38
|
Pastore AL, Palleschi G, Leto A, Silvestri
L, Porta N, Petrozza V and Carbone A: A novel combination of triple
metachronous malignancies of the kidney, oropharynx and prostate: A
case report. Oncol Lett. 10:917–920. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Adel M, Liao CT, Lee LY, Hsueh C, Lin CY,
Fan KH, Wang HM, Ng SH, Lin CH, Tsao CK, et al: Incidence and
outcomes of patients with oral cavity squamous cell carcinoma and
fourth primary tumors: A long-term follow-up study in a betel quid
chewing endemic area. Medicine (Baltimore). 95:e29502016.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Donin N, Filson C, Drakaki A, Tan HJ,
Castillo A, Kwan L, Litwin M and Chamie K: Risk of second primary
malignancies among cancer survivors in the United States, 1992
through 2008. Cancer. 122:3075–3086. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Babacan NA, Aksoy S, Cetin B, Ozdemir NY,
Benekli M, Uyeturk U, Ali Kaplan M, Kos T, Karaca H, Oksuzoglu B,
et al: Multiple primary malignant neoplasms: Multi-center results
from Turkey. J BUON. 17:770–775. 2012.PubMed/NCBI
|
|
42
|
Utada M, Ohno Y, Hori M and Soda M:
Incidence of multiple primary cancers and interval between first
and second primary cancers. Cancer Sci. 105:890–896. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yamashita T, Araki K, Tomifuji M, Tanaka
Y, Harada E, Suzuki T, Miyamoto S and Shiotani A: Clinical features
and treatment outcomes of Japanese head and neck cancer patients
with a second primary cancer. Asia Pac J Clin Oncol. 13:172–178.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Hung CY, Ueng SH, Lin YC and Chou WC:
Metastatic carcinoma of the urinary bladder in a 67-year-old female
with underlying triple primary cancers. J Cancer Res Pract.
3:49–53. 2016. View Article : Google Scholar
|
|
45
|
Shiels MS, Gibson T, Sampson J, Albanes D,
Andreotti G, Beane Freeman L, Berrington de Gonzalez A, Caporaso N,
Curtis RE, Elena J, et al: Cigarette smoking prior to first cancer
and risk of second smoking-associated cancers among survivors of
bladder, kidney, head and neck, and stage I lung cancers. J Clin
Oncol. 32:3989–3995. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Tiwana MS, Hay J, Wu J, Wong F, Cheung W
and Olson RA: Incidence of second metachronous head and neck
cancers: Population-based outcomes over 25 years. Laryngoscope.
124:2287–2291. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kundra V: Prostate cancer imaging. Semin
Roentgenol. 41:139–149. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kimura T, Onozawa M, Miyazaki J, Matsuoka
T, Joraku A, Kawai K, Nishiyama H, Hinotsu S and Akaza H:
Prognostic impact of young age on stage IV prostate cancer treated
with primary androgen deprivation therapy. Int J Urol. 21:578–583.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Miller KD, Siegel RL, Lin CC, Mariotto AB,
Kramer JL, Rowland JH, Stein KD, Alteri R and Jemal A: Cancer
treatment and survivorship statistics, 2016. CA Cancer J Clin.
66:271–289. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Strobel K, Haerle SK, Stoeckli SJ, Schrank
M, Soyka JD, Veit-Haibach P and Hany TF: Head and neck squamous
cell carcinoma (HNSCC)-detection of synchronous primaries with
(18)F-FDG PET/CT. Eur J Nucl Med Mol Imaging. 36:919–927. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Kondo N, Tsukuda M and Nishimura G:
Diagnostic sensitivity of 18fluorodeoxyglucose positron
emission tomography for detecting synchronous multiple primary
cancers in head and neck cancer patients. Eur Arch
Otorhinolaryngol. 269:1503–1507. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Hiraoka A, Hirooka M, Ochi H, Koizumi Y,
Shimizu Y, Shiraishi A, Yamago H, Tanihira T, Miyata H, Ninomiya T,
et al: Importance of screening for synchronous malignant neoplasms
in patients with hepatocellular carcinoma: Impact of FDG PET/CT.
Liver Int. 33:1085–1091. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Minamimoto R, Senda M, Terauchi T,
Jinnouchi S, Inoue T, Iinuma T, Inoue T, Ito K, Iwata H, Uno K, et
al: Analysis of various malignant neoplasms detected by FDG-PET
cancer screening program: Based on a Japanese Nationwide Survey.
Ann Nucl Med. 25:45–54. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Murakami R, Uozumi H, Hirai T, Nishimura
R, Shiraishi S, Ota K, Murakami D, Tomiguchi S, Oya N, Katsuragawa
S and Yamashita Y: Impact of FDG-PET/CT imaging on nodal staging
for head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol
Phys. 68:377–382. 2007. View Article : Google Scholar : PubMed/NCBI
|
